Market Overview:
The global genetic testing market is expected to reach USD XX million by 2030 from USD XX million in 2018, at a CAGR of XX%. The growth of this market can be attributed to the increasing incidence of genetic disorders, growing demand for personalized medicine, and technological advancements in genetic testing. Based on type, the global genetic testing market is segmented into analyzers and consumables. The analyzers segment is further divided into instruments and software & services. The consumables segment is further divided into reagents & kits and laboratory supplies. In terms of region, the global Genetic Testing Marketis analyzed across North America (U.S., Canada), Latin America (Mexico), Europe (Germany France Italy Spain U.K.), Asia Pacific(Japan China India Australia South Korea) Middle East Africa(GCC Countries Turkey Egypt South Africa).
Product Definition:
Genetic testing is the process of analyzing a person's DNA in order to identify abnormalities or mutations that may be associated with specific diseases or conditions. Genetic testing can be used to determine a person's risk of developing a particular disease, to help diagnose a disease, or to help guide decisions about treatment options.
Analyzers:
An analyzer is a tool that helps in analyzing and measuring the characteristics or attributes of an object under study. It may be used for testing, quality control, research & development, process monitoring and other industrial applications. Genetic analyzers are instruments that help detect genetic abnormalities in humans and other organisms by analyzing their DNA sequence or structure. They are widely used by clinical laboratories to analyze the level of gene expression for various diseases such as cancer or diabetes mellitus among others.
Consumables:
Consumables are the instruments or devices required for genetic testing. It includes reagents, kits, consumables liquids, and other accessories. Genetic testing is an analytical process that involves detection of an inherited or acquired mutation in DNA structure known as a gene.
Application Insights:
Predictive and diagnostic testing accounted for the largest revenue share in 2017. This is due to an increase in demand for genetic tests that can detect susceptibility to diseases early during a patient¢â‚¬â„¢s life. For instance, companies such as 23andMe are focusing on providing predictive information about health conditions that a person is likely to develop later in life through research studies with large datasets.
The prenatal testing segment is expected to grow at the fastest rate over the forecast period owing to an increase in women¢â‚¬â„¢s reproductive age, thereby increasing their chances of getting pregnant and giving birth. Prenatal diagnosis provides accurate risk assessment of chromosomal abnormalities during pregnancy so that appropriate preventive measures can be taken by patients or healthcare providers before conception occurs. Such factors are anticipated to boost demand for genetic tests conducted during pre-pregnancy periods, thereby driving growth from 2018to 2030 globally.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, availability of advanced technologies, and high adoption rate for technologically advanced products. Moreover, growing number of FDA-approved genetic tests is also expected to drive regional growth over the forecast period. Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising disposable income and improving healthcare infrastructure in emerging countries such as China and India. Furthermore, increasing investments by companies for developing novel diagnostic products will boost revenue generation in this region over the next eight years.
Major participants operating in this industry include 23andMe Inc.; Navigenics Corporation; deCODEme Inc.; PersonalGenome Laboratories Ltd.; BioDirection LLC; Glymour Biotech LLC; Unilife Corporation; Amgen Inc.
Growth Factors:
- Increasing demand for personalized medicine
- Growing public awareness about the benefits of genetic testing
- Rising prevalence of genetic disorders
- Technological advancements in genetic testing
- Growing demand for precision medicine
Scope Of The Report
Report Attributes
Report Details
Report Title
Genetic Testing Market Research Report
By Type
Analyzers, Consumables
By Application
Predictive and Diagnostic Testing, Prenatal, Newborn, and Pre-Implantation Testing, Pharmacogenomic Testing, Forensic, Relationship, and Ancestry Testing
By Companies
Abbott, bioMérieux, Bio-Rad Laboratories, F. Hoffmann-La Roche, Myriad Genetics, QIAGEN, Quest Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
192
Number of Tables & Figures
135
Customization Available
Yes, the report can be customized as per your need.
Global Genetic Testing Market Report Segments:
The global Genetic Testing market is segmented on the basis of:
Types
Analyzers, Consumables
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Predictive and Diagnostic Testing, Prenatal, Newborn, and Pre-Implantation Testing, Pharmacogenomic Testing, Forensic, Relationship, and Ancestry Testing
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- bioMérieux
- Bio-Rad Laboratories
- F. Hoffmann-La Roche
- Myriad Genetics
- QIAGEN
- Quest Diagnostics
Highlights of The Genetic Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Analyzers
- Consumables
- By Application:
- Predictive and Diagnostic Testing
- Prenatal, Newborn, and Pre-Implantation Testing
- Pharmacogenomic Testing
- Forensic, Relationship, and Ancestry Testing
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Genetic Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Genetic testing is a process by which genetic information can be obtained from a person or sample. This information can be used to diagnose and/or treat conditions that are caused by genetic abnormalities.
Some of the major players in the genetic testing market are Abbott, bioMƒÂ©rieux, Bio-Rad Laboratories, F. Hoffmann-La Roche, Myriad Genetics, QIAGEN, Quest Diagnostics.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Genetic Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Genetic Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Genetic Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Genetic Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Genetic Testing Market Size & Forecast, 2018-2028
4.5.1 Genetic Testing Market Size and Y-o-Y Growth
4.5.2 Genetic Testing Market Absolute $ Opportunity
Chapter 5 Global Genetic Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Genetic Testing Market Size Forecast by Type
5.2.1 Analyzers
5.2.2 Consumables
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Genetic Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Genetic Testing Market Size Forecast by Applications
6.2.1 Predictive and Diagnostic Testing
6.2.2 Prenatal
6.2.3 Newborn
6.2.4 and Pre-Implantation Testing
6.2.5 Pharmacogenomic Testing
6.2.6 Forensic
6.2.7 Relationship
6.2.8 and Ancestry Testing
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Genetic Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Genetic Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Genetic Testing Analysis and Forecast
9.1 Introduction
9.2 North America Genetic Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Genetic Testing Market Size Forecast by Type
9.6.1 Analyzers
9.6.2 Consumables
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Genetic Testing Market Size Forecast by Applications
9.10.1 Predictive and Diagnostic Testing
9.10.2 Prenatal
9.10.3 Newborn
9.10.4 and Pre-Implantation Testing
9.10.5 Pharmacogenomic Testing
9.10.6 Forensic
9.10.7 Relationship
9.10.8 and Ancestry Testing
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Genetic Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Genetic Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Genetic Testing Market Size Forecast by Type
10.6.1 Analyzers
10.6.2 Consumables
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Genetic Testing Market Size Forecast by Applications
10.10.1 Predictive and Diagnostic Testing
10.10.2 Prenatal
10.10.3 Newborn
10.10.4 and Pre-Implantation Testing
10.10.5 Pharmacogenomic Testing
10.10.6 Forensic
10.10.7 Relationship
10.10.8 and Ancestry Testing
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Genetic Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Genetic Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Genetic Testing Market Size Forecast by Type
11.6.1 Analyzers
11.6.2 Consumables
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Genetic Testing Market Size Forecast by Applications
11.10.1 Predictive and Diagnostic Testing
11.10.2 Prenatal
11.10.3 Newborn
11.10.4 and Pre-Implantation Testing
11.10.5 Pharmacogenomic Testing
11.10.6 Forensic
11.10.7 Relationship
11.10.8 and Ancestry Testing
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Genetic Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Genetic Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Genetic Testing Market Size Forecast by Type
12.6.1 Analyzers
12.6.2 Consumables
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Genetic Testing Market Size Forecast by Applications
12.10.1 Predictive and Diagnostic Testing
12.10.2 Prenatal
12.10.3 Newborn
12.10.4 and Pre-Implantation Testing
12.10.5 Pharmacogenomic Testing
12.10.6 Forensic
12.10.7 Relationship
12.10.8 and Ancestry Testing
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Genetic Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Genetic Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Genetic Testing Market Size Forecast by Type
13.6.1 Analyzers
13.6.2 Consumables
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Genetic Testing Market Size Forecast by Applications
13.10.1 Predictive and Diagnostic Testing
13.10.2 Prenatal
13.10.3 Newborn
13.10.4 and Pre-Implantation Testing
13.10.5 Pharmacogenomic Testing
13.10.6 Forensic
13.10.7 Relationship
13.10.8 and Ancestry Testing
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Genetic Testing Market: Competitive Dashboard
14.2 Global Genetic Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 bioMérieux
14.3.3 Bio-Rad Laboratories
14.3.4 F. Hoffmann-La Roche
14.3.5 Myriad Genetics
14.3.6 QIAGEN
14.3.7 Quest Diagnostics
